FDA Approvals in Oncology: April-June 2026
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
Tag: Sarcoma
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
People with alveolar soft part sarcoma can receive immunotherapy treatment for an extended period without long-term side effects.
New AI-driven models unveiled at the AACR Annual Meeting 2025 could revolutionize how we diagnose sarcomas in children.
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
Researchers share lessons from the first oncology clinical trial in Trinidad, which involved a patient named Faith Hill.
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
Most scientists, regardless of field or career stage, have faced difficulties networking and disseminating their research in the past year, with many conferences and symposia canceled. The...